Welcome to the 3rd GLP-1 Based Therapeutics Summit – the essential industry forum dedicated to solving the critical challenges of GLP-1 combinations, mastering tolerability, drug delivery, and seizing the multi-billion dollar opportunity in non-obesity indications. Driven by unprecedented clinical success, this revolutionary drug class has created multi-billion dollar franchises, but the market is now reaching a critical juncture […]

The SmartLab Exchange USA is an exclusive, invitation-only event designed for senior laboratory, R&D, and digital transformation leaders across pharma, biotech, chemicals, FMCG, and food & beverage. This two-day forum brings together more than 60 decision-makers to tackle one of the industry’s most pressing challenges: how to make lab digitalization work in practice. Every lab […]

As part of SAE’s leading PFS Series, the 2026 conference will once again bring together top experts, industry leaders, and innovators for a three-days of key insights and networking. The conference will feature a comprehensive pre-conference focus day dedicated to advancements in device design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the […]

The 5th ADC Analytical Development Summit is the industry’s only dedicated technical forum focused exclusively on solving the analytical challenges unique to antibody–drug conjugate (ADC) development. Designed for analytical, bioanalytical, and CMC leaders, the summit brings together senior experts from across pharma and biotech to advance analytical rigor, deepen product understanding, and enable regulatory-ready ADC […]

Peptide therapies are rapidly becoming a disruptive modality, led by Merck’s oral PCSK9 inhibitor and Johnson & Johnson’s IL23R, with the hope to develop best-in-class drugs with improved chemistry, formulation and clinical efficacy. To shine a light on the progress of this field, the highly anticipated 3rd Peptide-Based Therapeutics Summit returns to Boston as the industry’s only dedicated platform to turbocharge the next generation […]

Returning for its second year and building on the momentum of an inaugural edition that drew 100+ senior attendees, the 2nd Neuroscience Innovation Partnering & Licensing Summit is engineered to facilitate multiple high-impact, in-person meetings without the distractions of a broader, less-focused setting. Deliberately timed as an exclusive touchpoint for neuroscience business leaders to reconnect between […]

The GPCR field is experiencing a renaissance, driven by renewed investment, clinical progress, and next-generation technologies unlocking hundreds of previously untargeted receptors. Furthermore, we’ve recently seen Takeda and Iambic Therapeutics’ $1.7bn partnership to advance AI-driven small molecule programs, and Kainova Therapeutics securing $32m CAD to accelerate immuno-oncology and inflammation therapies, momentum in the GPCR space continues to build. The race is on to […]

Patient engagement has shifted from a “nice to have” to a strategic necessity. With regulators expecting defensible evidence, executives demanding clear ROI, and funding under tighter scrutiny, every engagement initiative must show measurable value. Yet many organizations still struggle to demonstrate the true impact of their work. The 3rd Measuring Patient Engagement Summit is the […]

Optimize Model Selection, Accelerate Timelines, Improve Predictivity of Toxicity Dates: May 12-14 | Location: Boston, MA Why Attend With nearly 90% of drug candidates failing in the clinic and one-third of those failures driven by safety preclinical toxicology has reached a critical inflection point. Traditional models are no longer sufficient to predict human risk, leading […]

New assets have entered clinic, whilst dozens more have been disclosed, and recent investments such as, T-Therapeutics’ $91M Series A extension to advance their bispecific towards the clinic and Anocca’s SEK 440M raise, pinpoint how funding and portfolio decisions have the power to define the trajectory of the TCR field. It is in this context that the 7th TCR-Based Therapies Summit returns to unite fellow biopharma experts in address shared […]

Biopharma investment into the formulation, delivery, and commercialization of intranasal therapies is at an all-time high, and there has never been such an opportunistic time to pursue nasal delivery. Alongside the market projection for intranasal therapies being forecasted to reach $21.2 billion by 2032, 2025 breakthroughs included Atzumi being approved for migraine treatment, and Eli Lilly’s Baqsimi now being […]

Returning for its 8th year, LEAP HR: Life Sciences West brings together 100+ senior HR leaders from scaling and stabilizing biotech organizations to navigate volatility and drive measurable business impact. Across three days of high-impact sessions, including case studies, benchmarking, roundtables, and structured networking, attendees will gain practical strategies to build lean HR functions, retain […]

The 5th ALS Drug Development Summit returns to Boston as the ultimate platform honing industry R&D for safer, more effect and patient-relevant drugs that serve the community, driving a cure for sporadic and familial ALS. With a brand-new agenda spanning early target exploration through to clinical design, biomarker strategy, and regulatory engagement, attendees will gain comprehensive insights into genetically validated […]

The 5th Extrahepatic Lipid-Based Nanoparticles Delivery Summit returns to Boston in June 2026 as the premier industry forum dedicated to advancing extrahepatic LNP delivery and next-generation targeted lipid nanoparticle technologies. As the field moves beyond liver-focused delivery, achieving precise, selective, tissue-specific targeting remains one of the most critical challenges in genetic medicine. With growing industry validation - including strategic acquisitions by AbbVie and Bristol Myers Squibb - confidence […]

The Future of R&D Procurement Excellence Starts Here! The 10th R&D Procurement & Sourcing in Pharma Summit returns to Boston in June 2026 as the definitive meeting place for procurement, sourcing and category management leaders across pre‑clinical and clinical R&D. This flagship event is designed to support procurement teams as they transition from transactional buying […]

Foster Innovation and Collaboration at the 10th Annual Pre-Filled Syringes and Injectable Drug Devices West Coast Conference! Join us in June 2026 as SAE Media Group’s renowned West Coast event returns, bringing together biotech pioneers, pharma leaders, and device innovators to shape the future of injectable drug delivery. This year’s conference will bring a brand […]

The 5th World ADC Summit South Korea (previously World ADC Asia), taking place 9–11 June 2026 in Seoul, stands as the Asia’s premier meeting dedicated to accelerating next‑generation antibody–drug conjugate (ADC) development. As South Korea rapidly transitions from a biosimilar‑focused market to a global innovator in precision oncology, ADCs have emerged as a centrepiece of […]

The World TPD & Induced Proximity Summit South Korea is the first and only Asian industry event dedicated exclusively to advancing targeted protein degradation (TPD) and induced proximity–based therapeutics. As the global TPD field enters a pivotal era, with the first PROTAC approval on the horizon and multiple candidates progressing through clinical trials, South Korea […]

The World Bispecific & T‑Cell Engager Summit South Korea is Asia’s first and only industry‑dedicated forum focused on advancing bispecific antibodies and T‑cell engagers (TCEs), modalities that are redefining the therapeutic landscape for solid tumors and immune‑driven diseases. Propelled by landmark regulatory approvals such as tarlatamab and ivonescimab, bispecifics and TCEs have captured global interest […]

8th T‑Cell Engager Therapeutics Summit — Your Flagship TCE Meeting The T‑cell engager field is evolving at an unprecedented pace. With multiple clinical approvals now validating the durability and therapeutic relevance of this modality, and a new wave of next‑generation solid tumor and autoimmune programs rapidly progressing toward the clinic, TCEs have firmly established themselves […]

Welcome to the 4th Obesity & Weight Loss Drug Development Summit - the definitive industry-forum dedicated to redefining the standards of metabolic medicine by mastering precision treatment, preserving functional health, and navigating the high-stakes transition to next-generation oral and multi-agonist therapies. The obesity therapeutics market has entered a radical transformation. Driven by the unprecedented success of first-generation incretins, the landscape has reached […]

Across the West Coast, Expanded Access Programs are entering a new phase. More companies are launching EAPs earlier in development, supporting patients for longer durations, and extending access beyond the U.S. into increasingly complex global markets. What was once a reactive, exception-based activity is now a visible, repeatable function - bringing heightened expectations around governance, […]

The 6th mRNA‑Based Therapeutics Summit: Accelerating the Next Era of mRNA Medicines The global mRNA landscape is advancing at unprecedented speed, propelled by scientific breakthroughs and high‑impact biopharma investment. Recent acquisitions – including Eli Lilly and Orna, BMS and Orbital, AbbVie and Capstan, and BioNTech and CureVac – underscore the momentum behind emerging modalities such […]

The 5th Liquid Biopsy for Precision Oncology Summit East Coast returns as your laser-focused forum dedicated to the acceleration, progression and real-world adoption of liquid biopsies. Expect to unite with 100+ biopharma professionals from Pfizer, AbbVie, Takeda, AstraZeneca, GSK and more to redefine your clinical trial strategies and advance oncology drug development forward. Boasting a […]

The 6th Medical Device Software Development Summit returns this July in Boston and brings together the specialists who are defining how AI-driven and software-based medical devices are built, validated, and submitted in an increasingly complex regulatory environment. AI is accelerating innovation faster than traditional compliance models can keep up. FDA expectations for AI-enabled devices continue […]

As the only conference focused on neoantigens, the 9th International Neoantigen Summit returns to Amsterdam as the most timely and essential gathering for the field. As your only chance this year to learn about the latest clinical data in the field and address the full translational journey – from antigen identification and validation through to biomarker strategy, clinical trial […]

4th ADC Linker & Conjugation Summit Linking Chemistry to Clinical Success Through Better ADC Design When? July 28-30, 2026 Where? Boston, MA ADC development is evolving fast, with developers pushing beyond traditional cytotoxins into dual‑payload constructs, high‑DAR species, degrader–antibody conjugates, and next‑generation modalities. This surge in innovation is placing new pressure on linker architecture and […]

The 5th In Vivo Cell Engineering & Gene Editing Summit returns as the leading industry meeting dedicated to advancing the next generation of in vivo delivery platforms, gene editing tools, and translational strategies that support safe, precise, and scalable genetic medicines. Designed for scientists, technical leaders, and strategic decision-makers across biopharma, this summit provides a […]

The 3rd Annual Lab Ops & Facility Management for Biopharma West Summit is the West Coast’s dedicated meeting for Lab Operations and Facilities leaders who are being asked to do more with less while keeping scientists productive and R&D environments running at the highest standard. With tighter budgets, workforce fluctuations, and rapid pipeline shifts reshaping day-to-day priorities, […]

The 6th Annual Oligonucleotides for CNS Summit USA returns to Boston on 19–21 August 2026, uniting 160+ leaders across pharma and biotech to accelerate the discovery, translation and clinical success of CNS‑targeted oligonucleotide therapies. As advances in RNA chemistry, delivery technologies and clinical evidence unlock previously undruggable CNS targets, this meeting is the industry’s most […]